
Edgewise Therapeutics, Inc.
USD39.58
+0.77 (+1.98%)
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.79
Prev. Close
$38.81
Day Low
$38.79
Day High
$39.97
52W Low
$12.30
52W High
$48.40
Market Cap
$4.26B
Volume
0.54M
| 16 Jun 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 2 Jun 2026 | Wedbush | Outperform | Outperform | maintain |
| 2 Jun 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 2 Jun 2026 | RBC Capital | Outperform | Outperform | maintain |
| 17 Mar 2026 | JP Morgan | Overweight | Overweight | maintain |
| 17 Mar 2026 | Wedbush | Outperform | Outperform | maintain |
| 27 Feb 2026 | Evercore ISI Group | Outperform | Outperform | maintain |